| Title : Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury - Wicinski_2020_Pharmaceuticals.(Basel)_13_ |
| Author(s) : Wicinski M , Wodkiewicz E , Gorski K , Walczak M , Malinowski B |
| Ref : Pharmaceuticals (Basel) , 13 : , 2020 |
| Abstract : |
| PubMedSearch : Wicinski_2020_Pharmaceuticals.(Basel)_13_ |
| PubMedID: 33187206 |
| Title : Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury - Wicinski_2020_Pharmaceuticals.(Basel)_13_ |
| Author(s) : Wicinski M , Wodkiewicz E , Gorski K , Walczak M , Malinowski B |
| Ref : Pharmaceuticals (Basel) , 13 : , 2020 |
| Abstract : |
| PubMedSearch : Wicinski_2020_Pharmaceuticals.(Basel)_13_ |
| PubMedID: 33187206 |
| Title : Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury - Wicinski_2020_Pharmaceuticals.(Basel)_13_ |
| Author(s) : Wicinski M , Wodkiewicz E , Gorski K , Walczak M , Malinowski B |
| Ref : Pharmaceuticals (Basel) , 13 : , 2020 |
| Abstract : |
| PubMedSearch : Wicinski_2020_Pharmaceuticals.(Basel)_13_ |
| PubMedID: 33187206 |